Skip to main content
Top
Published in: Clinical Oral Investigations 3/2014

01-04-2014 | Original Article

DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma

Authors: Yung-Kai Huang, Bou-Yu Peng, Chia-Yo Wu, Chien-Tien Su, Hui-Chen Wang, Hung-Cheng Lai

Published in: Clinical Oral Investigations | Issue 3/2014

Login to get access

Abstract

Objectives

DNA methylation has been shown to be a promising cancer biomarker. The aim of this study was to evaluate DNA methylation of three transcription factors, sex-determining region Y-box 1 (SOX1), paired box gene 1 (PAX1), and zinc-finger 582 (ZNF582), in detecting oral squamous cell carcinoma (OSCC).

Materials and methods

A case–control study was conducted at Taipei Medical University Hospital in Taiwan with 31 cases of various oral cavity squamous cell carcinomas and 40 controls. Questionnaire data assessing environmental exposure, such as alcohol consumption, cigarette smoking, and betel nut chewing, were obtained from each participant. DNA from oral swabs were analyzed for methylation using quantitative methylation polymerase chain reaction with TaqMan probes. Methylation status was determined using a methylation index.

Results

Methylation levels of SOX1, PAX1, and ZNF582 were significantly higher in cancer patients (p = 0.02, p = 0.02, and p = 0.03, respectively). Patients with highly methylated SOX1, PAX1, and ZNF582 had an increased cancer risk with odds ratios (ORs) of 16.50 (95 % CI = 2.85–96.65), 60.57 (95 % CI = 5.85–629.94), and 5.07 (95 % CI = 1.08–23.76), respectively. Area under the curve (AUC) values were 0.85, 0.78, and 0.78 for PAX1, SOX1, and ZNF582, respectively. When stratified based on environmental exposure, the AUC of PAX1 methylation (PAX1 m ) was 0.94 in environmental exposure-naïve subjects and 0.85 for SOX1 methylation in subjects who chewed betel nut. In general, the sensitivity and specificity of PAX1 m were 87 and 80 % for OSCC detection. The sensitivity of PAX1 m in subjects who chewed betel nut was 83 %, with a specificity of 75 %.

Conclusions

Testing PAX1 DNA methylation using oral swabs is a promising method for oral cancer detection. Combined assessments regarding betel nut consumption and DNA methylation can improve OSCC screening.

Clinical relevance

The double E (environmental and epigenetic) assessment is a potential strategy in OSCC screening.
Literature
1.
go back to reference Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316PubMedCrossRef Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309–316PubMedCrossRef
2.
go back to reference Petersen PE (2009) Oral cancer prevention and control—the approach of the World Health Organization. Oral Oncol 45:454–460PubMedCrossRef Petersen PE (2009) Oral cancer prevention and control—the approach of the World Health Organization. Oral Oncol 45:454–460PubMedCrossRef
3.
go back to reference Petersen PE, Kwan S (2011) Equity, social determinants and public health programmes—the case of oral health. Community Dent Oral Epidemiol 39:481–487PubMedCrossRef Petersen PE, Kwan S (2011) Equity, social determinants and public health programmes—the case of oral health. Community Dent Oral Epidemiol 39:481–487PubMedCrossRef
4.
go back to reference Jeng JH, Chang MC, Hahn LJ (2001) Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 37:477–492PubMedCrossRef Jeng JH, Chang MC, Hahn LJ (2001) Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol 37:477–492PubMedCrossRef
5.
go back to reference Department of Health ROC (2010) Bureau of Health Promotion Annual Report. Department of Health, ROC. Department of Health, Executive Yuan, Taipei Department of Health ROC (2010) Bureau of Health Promotion Annual Report. Department of Health, ROC. Department of Health, Executive Yuan, Taipei
7.
go back to reference Schwartz AG, Prysak GM, Bock CH, Cote ML (2006) The molecular epidemiology of lung cancer. Carcinogenesis 28:507–518PubMedCrossRef Schwartz AG, Prysak GM, Bock CH, Cote ML (2006) The molecular epidemiology of lung cancer. Carcinogenesis 28:507–518PubMedCrossRef
8.
go back to reference Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M (2011) Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6:692–702PubMedCrossRef Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M (2011) Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6:692–702PubMedCrossRef
9.
go back to reference Lai HC, Lin YW, Huang THM, Yan P, Huang RL, Wang HC, Liu J, Chan MWY, Chu TY, Sun CA, Chang CC, Yu MH (2008) Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 123:161–167PubMedCrossRef Lai HC, Lin YW, Huang THM, Yan P, Huang RL, Wang HC, Liu J, Chan MWY, Chu TY, Sun CA, Chang CC, Yu MH (2008) Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 123:161–167PubMedCrossRef
10.
go back to reference Lai HC, Lin YW, Huang RL, Chung MT, Wang HC, Liao YP, Su PH, Liu YL, Yu MH (2010) Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer 116:4266–4274PubMedCrossRef Lai HC, Lin YW, Huang RL, Chung MT, Wang HC, Liao YP, Su PH, Liu YL, Yu MH (2010) Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer 116:4266–4274PubMedCrossRef
11.
go back to reference Kaur J, Demokan S, Tripathi SC, Macha MA, Begum S, Califano JA, Ralhan R (2010) Promoter hypermethylation in indian primary oral squamous cell carcinoma. Int J Cancer 127:2367–2373PubMedCentralPubMedCrossRef Kaur J, Demokan S, Tripathi SC, Macha MA, Begum S, Califano JA, Ralhan R (2010) Promoter hypermethylation in indian primary oral squamous cell carcinoma. Int J Cancer 127:2367–2373PubMedCentralPubMedCrossRef
12.
go back to reference Nagata S, Hamada T, Yamada N, Yokoyama S, Kitamoto S, Kanmura Y, Nomura M, Kamikawa Y, Yonezawa S, Sugihara K (2012) Aberrant DNA methylation of tumor-related genes in oral rinse. Cancer 118:4298–4308PubMedCrossRef Nagata S, Hamada T, Yamada N, Yokoyama S, Kitamoto S, Kanmura Y, Nomura M, Kamikawa Y, Yonezawa S, Sugihara K (2012) Aberrant DNA methylation of tumor-related genes in oral rinse. Cancer 118:4298–4308PubMedCrossRef
13.
go back to reference Pattani KM, Zhang Z, Demokan S, Glazer C, Loyo M, Goodman S, Sidransky D, Bermudez F, Jean-Charles G, McCaffrey T, Padhya T, Phelan J, Spivakovsky S, Bowne HY, Goldberg JD, Rolnitzky L, Robbins M, Kerr AR, Sirois D, Califano JA (2010) Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res 3:1093–1103CrossRef Pattani KM, Zhang Z, Demokan S, Glazer C, Loyo M, Goodman S, Sidransky D, Bermudez F, Jean-Charles G, McCaffrey T, Padhya T, Phelan J, Spivakovsky S, Bowne HY, Goldberg JD, Rolnitzky L, Robbins M, Kerr AR, Sirois D, Califano JA (2010) Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res 3:1093–1103CrossRef
14.
go back to reference Phillips JM, Goodman JI (2009) Inhalation of cigarette smoke induces regions of altered DNA methylation (RAMs) in SENCAR mouse lung. Toxicology 260:7–15PubMedCrossRef Phillips JM, Goodman JI (2009) Inhalation of cigarette smoke induces regions of altered DNA methylation (RAMs) in SENCAR mouse lung. Toxicology 260:7–15PubMedCrossRef
15.
go back to reference Syrjanen S, Lodi G, von Bultzingslowen I, Aliko A, Arduino P, Campisi G, Challacombe S, Ficarra G, Flaitz C, Zhou HM, Maeda H, Miller C, Jontell M (2011) Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Diseases 17:58–72PubMedCrossRef Syrjanen S, Lodi G, von Bultzingslowen I, Aliko A, Arduino P, Campisi G, Challacombe S, Ficarra G, Flaitz C, Zhou HM, Maeda H, Miller C, Jontell M (2011) Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Diseases 17:58–72PubMedCrossRef
16.
go back to reference Nair S, Pillai MR (2005) Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis 11:350–359PubMedCrossRef Nair S, Pillai MR (2005) Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis 11:350–359PubMedCrossRef
17.
go back to reference Molinolo AA, Marsh C, El DM, Gangane N, Jennison K, Hewitt S, Patel V, Seiwert TY, Gutkind JS (2012) mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas. Clin Cancer Res 18:2558–2568PubMedCentralPubMedCrossRef Molinolo AA, Marsh C, El DM, Gangane N, Jennison K, Hewitt S, Patel V, Seiwert TY, Gutkind JS (2012) mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas. Clin Cancer Res 18:2558–2568PubMedCentralPubMedCrossRef
18.
go back to reference Zushi Y, Narisawa-Saito M, Noguchi K, Yoshimatsu Y, Yugawa T, Egawa N, Fujita M, Urade M, Kiyono T (2011) An in vitro multistep carcinogenesis model for both HPV-positive and -negative human oral squamous cell carcinomas. Am J Cancer Res 1:869–881PubMedCentralPubMed Zushi Y, Narisawa-Saito M, Noguchi K, Yoshimatsu Y, Yugawa T, Egawa N, Fujita M, Urade M, Kiyono T (2011) An in vitro multistep carcinogenesis model for both HPV-positive and -negative human oral squamous cell carcinomas. Am J Cancer Res 1:869–881PubMedCentralPubMed
19.
go back to reference Huang RL, Chang CC, Su PH, Chen YC, Liao YP, Wang HC, Yo YT, Chao TK, Huang HC, Lin CY, Chu TY, Lai HC (2012) Methylomic analysis identifies frequent DNA methylation of Zinc Finger Protein 582 (ZNF582) in cervical neoplasms. PLoS One 7:e41060PubMedCentralPubMedCrossRef Huang RL, Chang CC, Su PH, Chen YC, Liao YP, Wang HC, Yo YT, Chao TK, Huang HC, Lin CY, Chu TY, Lai HC (2012) Methylomic analysis identifies frequent DNA methylation of Zinc Finger Protein 582 (ZNF582) in cervical neoplasms. PLoS One 7:e41060PubMedCentralPubMedCrossRef
20.
go back to reference Angadi PV, Savitha JK, Rao SS, Sivaranjini Y (2012) Oral field cancerization: current evidence and future perspectives. Oral Maxillofac Surg 16:171–180PubMedCrossRef Angadi PV, Savitha JK, Rao SS, Sivaranjini Y (2012) Oral field cancerization: current evidence and future perspectives. Oral Maxillofac Surg 16:171–180PubMedCrossRef
21.
go back to reference Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28:E32PubMedCentralPubMedCrossRef Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28:E32PubMedCentralPubMedCrossRef
22.
go back to reference Reesink-Peters N, Wisman GB, Jeronimo C, Tokumaru CY, Cohen Y, Dong SM, Klip HG, Buikema HJ, Suurmeijer AJ, Hollema H, Boezen HM, Sidransky D, van der Zee AG (2004) Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2:289–295PubMed Reesink-Peters N, Wisman GB, Jeronimo C, Tokumaru CY, Cohen Y, Dong SM, Klip HG, Buikema HJ, Suurmeijer AJ, Hollema H, Boezen HM, Sidransky D, van der Zee AG (2004) Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. Mol Cancer Res 2:289–295PubMed
23.
go back to reference Perkins NJ, Schisterman EF (2006) The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 163:670–675PubMedCentralPubMedCrossRef Perkins NJ, Schisterman EF (2006) The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 163:670–675PubMedCentralPubMedCrossRef
24.
go back to reference Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, Pandey M, Ramadas K, Najeeb K, Abraham E (2000) Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 88:664–673PubMedCrossRef Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, Pandey M, Ramadas K, Najeeb K, Abraham E (2000) Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer 88:664–673PubMedCrossRef
25.
26.
go back to reference Awan K, Yang Y, Morgan P, Warnakulasuriya S (2012) Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity—a clinical and histological assessment. Oral Dis 18:728–733PubMedCrossRef Awan K, Yang Y, Morgan P, Warnakulasuriya S (2012) Utility of toluidine blue as a diagnostic adjunct in the detection of potentially malignant disorders of the oral cavity—a clinical and histological assessment. Oral Dis 18:728–733PubMedCrossRef
27.
go back to reference Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6:963–968PubMedCrossRef Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 6:963–968PubMedCrossRef
28.
go back to reference Giovannucci E, Ogino S (2005) DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 97:1317–1319PubMedCrossRef Giovannucci E, Ogino S (2005) DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 97:1317–1319PubMedCrossRef
29.
go back to reference Wang KH, Liu HW, Lin SR, Ding DC, Chu TY (2009) Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings. Cancer Sci 100:2175–2180PubMedCrossRef Wang KH, Liu HW, Lin SR, Ding DC, Chu TY (2009) Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings. Cancer Sci 100:2175–2180PubMedCrossRef
30.
go back to reference Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW, Skinner KA (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 60:5021–5026PubMed Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW, Skinner KA (2000) Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 60:5021–5026PubMed
31.
go back to reference Lee YC, Wang HP, Wang CP, Ko JY, Lee JM, Chiu HM, Lin JT, Yamashita S, Oka D, Watanabe N, Matsuda Y, Ushijima T, Wu MS (2011) Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers. Cancer Prev Res 4:1982–1992CrossRef Lee YC, Wang HP, Wang CP, Ko JY, Lee JM, Chiu HM, Lin JT, Yamashita S, Oka D, Watanabe N, Matsuda Y, Ushijima T, Wu MS (2011) Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: better risk assessment with epigenetic markers. Cancer Prev Res 4:1982–1992CrossRef
33.
go back to reference Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA (2007) PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol 73:1–14PubMedCrossRef Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA (2007) PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol 73:1–14PubMedCrossRef
34.
go back to reference Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, Widschwendter M (2009) DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer 125:2995–3002PubMedCrossRef Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, Widschwendter M (2009) DNA methylation analysis in liquid-based cytology for cervical cancer screening. Int J Cancer 125:2995–3002PubMedCrossRef
35.
go back to reference Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH (2009) An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer 124:387–393PubMedCrossRef Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH (2009) An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer 124:387–393PubMedCrossRef
36.
go back to reference Chun M, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, Li HJ, Lin YW (2012) SOX1 functions as a tumor suppressor through antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatologyimpress Chun M, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, Li HJ, Lin YW (2012) SOX1 functions as a tumor suppressor through antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatologyimpress
37.
go back to reference Mathews LA, Hurt EM, Zhang X, Farrar WL (2010) Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells. Mol Cancer 9:267–283PubMedCentralPubMedCrossRef Mathews LA, Hurt EM, Zhang X, Farrar WL (2010) Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells. Mol Cancer 9:267–283PubMedCentralPubMedCrossRef
38.
go back to reference Lim EH, Ng SL, Li JL, Chang AR, Ng J, Ilancheran A, Low J, Quek SC, Tay EH (2010) Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol 119:225–231PubMedCrossRef Lim EH, Ng SL, Li JL, Chang AR, Ng J, Ilancheran A, Low J, Quek SC, Tay EH (2010) Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy. Gynecol Oncol 119:225–231PubMedCrossRef
39.
go back to reference Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC, Chu TY (2010) Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer. Int J Gynecol Cancer 20:513–519PubMedCrossRef Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC, Chu TY (2010) Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer. Int J Gynecol Cancer 20:513–519PubMedCrossRef
41.
go back to reference Gasche JA, Hoffmann J, Boland CR, Goel A (2011) Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 129:1053–1063PubMedCentralPubMedCrossRef Gasche JA, Hoffmann J, Boland CR, Goel A (2011) Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer 129:1053–1063PubMedCentralPubMedCrossRef
42.
go back to reference IARC. (2004) Betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. In: IARC monographs on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, Lyon, Franch, pp 1–333 IARC. (2004) Betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. In: IARC monographs on the evaluation of carcinogenic risks to humans. International Agency for Research on Cancer, Lyon, Franch, pp 1–333
43.
go back to reference Chang MC, Chiang CP, Lin CL, Lee JJ, Hahn LJ, Jeng JH (2005) Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol 41:757–775PubMedCrossRef Chang MC, Chiang CP, Lin CL, Lee JJ, Hahn LJ, Jeng JH (2005) Cell-mediated immunity and head and neck cancer: with special emphasis on betel quid chewing habit. Oral Oncol 41:757–775PubMedCrossRef
44.
go back to reference Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42:561–568PubMedCrossRef Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42:561–568PubMedCrossRef
45.
go back to reference Lin PC, Chang WH, Chen YH, Lee CC, Lin YH, Chang JG (2011) Cytotoxic effects produced by arecoline correlated to epigenetic regulation in human K-562 cells. J Toxicol Environ Health A 74:737–745PubMedCrossRef Lin PC, Chang WH, Chen YH, Lee CC, Lin YH, Chang JG (2011) Cytotoxic effects produced by arecoline correlated to epigenetic regulation in human K-562 cells. J Toxicol Environ Health A 74:737–745PubMedCrossRef
46.
go back to reference Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC (1989) Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res 49:5294–5298PubMed Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC (1989) Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res 49:5294–5298PubMed
47.
go back to reference Rao AR, Das P (1989) Evaluation of the carcinogenicity of different preparations of areca nut in mice. Int J Cancer 43:728–732PubMedCrossRef Rao AR, Das P (1989) Evaluation of the carcinogenicity of different preparations of areca nut in mice. Int J Cancer 43:728–732PubMedCrossRef
48.
go back to reference Suri K, Goldman HM, Wells H (1971) Carcinogenic effect of a dimethyl sulphoxide extract of betel nut on the mucosa of the hamster buccal pouch. Nature 230:383–384PubMedCrossRef Suri K, Goldman HM, Wells H (1971) Carcinogenic effect of a dimethyl sulphoxide extract of betel nut on the mucosa of the hamster buccal pouch. Nature 230:383–384PubMedCrossRef
49.
go back to reference Chang LY, Wan HC, Lai YL, Kuo YF, Liu TY, Chen YT, Hung SL (2009) Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-α, interleukin-1β, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells. J of Periodontal Res 44:175–183CrossRef Chang LY, Wan HC, Lai YL, Kuo YF, Liu TY, Chen YT, Hung SL (2009) Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-α, interleukin-1β, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells. J of Periodontal Res 44:175–183CrossRef
50.
go back to reference Shiu MN, Chen TH, Chang SH, Hahn LJ (2000) Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 82:1871–1874PubMedCentralPubMedCrossRef Shiu MN, Chen TH, Chang SH, Hahn LJ (2000) Risk factors for leukoplakia and malignant transformation to oral carcinoma: a leukoplakia cohort in Taiwan. Br J Cancer 82:1871–1874PubMedCentralPubMedCrossRef
51.
go back to reference Shiu MN, Chen TH (2004) Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev 13:39–45PubMedCrossRef Shiu MN, Chen TH (2004) Impact of betel quid, tobacco and alcohol on three-stage disease natural history of oral leukoplakia and cancer: implication for prevention of oral cancer. Eur J Cancer Prev 13:39–45PubMedCrossRef
52.
go back to reference Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, Balija M (2012) Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Medicina Oral Patologia Oral y Cirugia Bucal 17:E10–E15CrossRef Brailo V, Vucicevic-Boras V, Lukac J, Biocina-Lukenda D, Zilic-Alajbeg I, Milenovic A, Balija M (2012) Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer. Medicina Oral Patologia Oral y Cirugia Bucal 17:E10–E15CrossRef
Metadata
Title
DNA methylation of PAX1 as a biomarker for oral squamous cell carcinoma
Authors
Yung-Kai Huang
Bou-Yu Peng
Chia-Yo Wu
Chien-Tien Su
Hui-Chen Wang
Hung-Cheng Lai
Publication date
01-04-2014
Publisher
Springer Berlin Heidelberg
Published in
Clinical Oral Investigations / Issue 3/2014
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-013-1048-6

Other articles of this Issue 3/2014

Clinical Oral Investigations 3/2014 Go to the issue